The ROE (Return on Equity) of Kiniksa Pharmaceuticals International PLC (KNSA) is -9.85%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -9.85% |
| 2023-12-31 | 3.21% |
| 2022-12-31 | 46.29% |
| 2021-12-31 | -85.36% |
| 2020-12-31 | -51.74% |
| 2019-12-31 | -71.81% |
| 2018-12-31 | -36.96% |
| 2017-12-31 | -215.52% |
| 2016-12-31 | -44.23% |